Dose Schedule and Antitumor Studies of Arabinosyl Cytosine ( NSC 6387 S ) 6 7 Writing Committee

The University of Oklahoma Medical Center, Oklahoma City, Oklahoma The University of Texas Medical Branch, Galveston, Texas ^he University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, Texas The University of Texas Southwestern Medical School, Dallas, Texas Tulane University School of Medicine, New Orleans, Louisiana University of Arkansas Medical Center, Little Rock, Arkansas University of Virginia School of Medicine, Charlottesville, Vir ginia Washington University School of Medicine, St. Louis, Missouri Wilford Hall USAF Hospital, Lackland Air Force Base, Texas

[1]  E. Cronkite,et al.  The Use of Tritiated Thymidine in the Study of Haemopoletic Cell Proliferation , 2008 .

[2]  E. Cronkite,et al.  Mitotic Indices of Human Bone Marrow Cells , 2005 .

[3]  W. Looney,et al.  Cell proliferation and tumor growth in hepatomas 3924A. , 1971, Cancer research.

[4]  J. Harris,et al.  The effect of 1-beta-D-arabinofuranosylcytosine on the immune response of mice to sheep red blood cells. , 1968, Cancer research.

[5]  J. Gowans.  Immunobiology of the Small Lymphocyte , 1968 .

[6]  P. Carbone,et al.  A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878). , 1968, Cancer research.

[7]  J. Holland,et al.  Continuous infusions of arabinosyl cytosine in patients with neoplastic disease , 1967, Clinical pharmacology and therapeutics.

[8]  L. Campbell,et al.  Nuclear Bleb Formation in Human Bone Marrow Cells during Cytosine Arabinoside Therapy , 1967, Nature.

[9]  H. Skipper,et al.  Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. , 1967, Cancer chemotherapy reports.

[10]  M. Tubiana,et al.  Kinetics of cell proliferation of an experimental tumor. , 1967, Cancer research.

[11]  R. Taylor.  Ninth international cancer congress , 1967 .

[12]  J. Fried,et al.  Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. , 1967, The Journal of clinical investigation.

[13]  R. Talley,et al.  Clinical pharmacology and human antitumor activity of cytosine arabinoside , 1967, Cancer.

[14]  P. Calabresi,et al.  Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man. , 1966, Biochemical pharmacology.

[15]  M. Murphy,et al.  Cytosine arabinoside (NSC-63878) in acute leukemia in children. , 1966, Cancer chemotherapy reports.

[16]  L. Lajtha.  Cytokinetics and regulation of progenitor cells , 1966, Journal of cellular physiology.

[17]  P. Carbone,et al.  Cytogenetic and morphologie abnormalities in human bone marrow cells during cytosine arabinoside therapy. , 1966, Blood.

[18]  W. R. Bruce,et al.  Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to tritiated thymidine. , 1965, Journal of the National Cancer Institute.

[19]  K. Merritt,et al.  Effect of uracil mustard and several antitumor drugs on the primary antibody response in rats and mice. , 1965, Journal of the National Cancer Institute.

[20]  R. Adamson,et al.  Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878). , 1965, Cancer chemotherapy reports.

[21]  D. Rall,et al.  The Stathmokinetic Effect of Vincristine , 1964 .

[22]  S. Cohen,et al.  SOME METABOLIC PROPERTIES OF NUCLEOTIDES OF 1-BETA-D-ARABINO-FURANOSYLCYTOSINE. , 1964, Cancer research.

[23]  J. Evans,et al.  The Effect of 1-β-d-Arabinofuranosylcytosine Hydrochloride on Murine Neoplasms , 1964 .

[24]  L. Bostwick,et al.  SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN. , 1964, Biochemical pharmacology.

[25]  E. D. Maloney,et al.  IDU and cytosine arabinoside in experimental herpetic keratitis. , 1963, Archives of ophthalmology.

[26]  V. Vaitkevicius,et al.  Megaloblastosis Produced by a Cytosine Antagonist , 1963 .

[27]  E. Cronkite,et al.  Mitotic indices of human bone marrow cells. II. The use of mitotic indices for estimation of time parameters of proliferation in serially connected multiplicative cellular compartments. , 1963, Blood.

[28]  M. Chu,et al.  A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells. , 1962, Biochemical pharmacology.

[29]  E. Cronkite,et al.  Mitotic indices of human bone marrow cells. I. Number and cytologic distribution of mitoses. , 1962, Blood.

[30]  V. Vaitkevicius,et al.  Cytological and clinical observations during vincaleukoblastine therapy of disseminated cancer , 1962, Cancer.

[31]  J. Holland.  Symposium on the experimental pharmacology and clinical use of antimetabolites. VII. Folic acid antagonists. , 1961, Clinical pharmacology and therapeutics.

[32]  L. Pizer,et al.  Metabolism of pyrimidine arabinonucleosides and cyclonucleosides in Escherichia coli. , 1960, The Journal of biological chemistry.